TRANslationell Teranostik - Utveckling av radioaktiva läkemedel för diagnostik och terapi – Thuy Trans forskargrupp

Publikationer

Utvalda publikationer

• Article: THERANOSTICS. 2019;9(8):2129-2142

  Preclinical efficacy of hK2 targeted [177Lu]hu11B6 for prostate cancer theranostics.

  Timmermand OV; Elgqvist J; Beattie KA; Örbom A; Larsson E; Eriksson SE; Thorek DLJ; Beattie BJ; Tran TA; Ulmert D; Strand S-E
• Article: EJNMMI RESEARCH. 2018;8(1):25

  Treatment response assessment with (R)-[11CPAQ PET in the MMTV-PyMT mouse model of breast cancer.

  Tegnebratt T; Lu L; Eksborg S; Chireh A; Damberg P; Nikkhou-Aski S; Foukakis T; Rundqvist H; Holmin S; Kuiper RV; Samen E
• Article: EJNMMI RESEARCH. 2014;4(1):51

  Preclinical imaging of kallikrein-related peptidase 2 (hK2) in prostate cancer with a (111)In-radiolabelled monoclonal antibody, 11B6.

  Timmermand OV; Ulmert D; Evans-Axelsson S; Pettersson K; Bjartell A; Lilja H; Strand S-E; Tran TA
• Article: EJNMMI RESEARCH. 2014;4(1):34

  Evaluation of efficacy of a new MEK inhibitor, RO4987655, in human tumor xenografts by [(18)F] FDG-PET imaging combined with proteomic approaches.

  Tegnebratt T; Ruge E; Bader S; Ishii N; Aida S; Yoshimura Y; Ooi C-H; Lu L; Mitsios N; Meresse V; Mulder J; Pawlak M; Venturi M; Tessier J; Stone-Elander S
• Article: APPLIED RADIATION AND ISOTOPES. 2014;94:294-301

  A solid target system with remote handling of irradiated targets for PET cyclotrons.

  Siikanen J; Tran TA; Olsson TG; Strand S-E; Sandell A

Medlemmar och kontakt

Gruppledare

• 

  Thuy Tran

  Anknuten till Forskning

  E-postadress thuy.tran@ki.se

Alla medlemmar i gruppen

• 

  Thuy Tran

  Anknuten till Forskning

  E-postadress thuy.tran@ki.se